Literature DB >> 10976641

Selective pathological changes of the periaqueductal gray matter in Alzheimer's disease.

J Parvizi1, G W Van Hoesen, A Damasio.   

Abstract

The periaqueductal gray matter (PAG) is a major neuroanatomical component of the brainstem and has pivotal roles in autonomic functions, behavior, and cognition, most notably in the processing of emotions and feelings. In a study of 32 brains obtained from patients with Alzheimer's disease (AD), thioflavin S-stained sections from the PAG contained major pathological changes in 81% of cases. These changes were absent in all 26 control brains (13 from normal subjects and 13 from non-AD patients). In the AD cases, both sides of the PAG were affected symmetrically; in 72%, there were only senile plaques, but there were both senile plaques and neurofibrillary tangles in 9%. Using immunohistochemical methods with 10D5, ALZ-50, and AT8 antibodies, we also established the presence of beta-amyloid peptide and abnormally phosphorylated tau protein in the PAG. Furthermore, we found that the type and density of pathological changes were expressed differently in different PAG regions and correlated with gender and the duration of dementia. These findings constitute a first step in documenting the selective changes of PAG in AD. The compartmentalized pattern of AD changes in PAG also reveals for the first time the columnar organization of PAG in human subjects.

Entities:  

Mesh:

Year:  2000        PMID: 10976641

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  Differential involvement of the periaqueductal gray in multiple system atrophy.

Authors:  Eduardo E Benarroch; Ann M Schmeichel; Phillip A Low; Joseph E Parisi
Journal:  Auton Neurosci       Date:  2010-08-21       Impact factor: 3.145

Review 2.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

Review 3.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 4.  Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research.

Authors:  Todd B Monroe; John C Gore; Li Min Chen; Lorraine C Mion; Ronald L Cowan
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-12-31       Impact factor: 2.680

5.  Policy Implications for Pain in Advanced Alzheimer's Disease.

Authors:  Alison R Anderson; Karen Hyden; Michelle D Failla; Michael A Carter
Journal:  Pain Manag Nurs       Date:  2020-07-16       Impact factor: 1.929

Review 6.  Neuroimaging of the periaqueductal gray: state of the field.

Authors:  Clas Linnman; Eric A Moulton; Gabi Barmettler; Lino Becerra; David Borsook
Journal:  Neuroimage       Date:  2011-12-14       Impact factor: 6.556

7.  Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia.

Authors:  E E Benarroch; A M Schmeichel; B N Dugger; P Sandroni; J E Parisi; P A Low
Journal:  Neurology       Date:  2009-07-14       Impact factor: 9.910

8.  Midbrain atrophy in subcortical ischemic vascular dementia.

Authors:  Young-Hee Sung; Ki-Hyung Park; Yeung-Bae Lee; Hyeon-Mi Park; Dong Jin Shin; Jea-Sul Park; Mi-Sun Oh; Hyeo-Il Ma; Kyung-Ho Yu; Suk-Yun Kang; Yun Joong Kim; Byung-Chul Lee
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

9.  The periaqueductal grey area and control of blood pressure in neurodegeneration.

Authors:  Holly Sitsapesan; Alexander L Green; Tipu Z Aziz; Erlick A C Pereira
Journal:  Clin Auton Res       Date:  2013-06-30       Impact factor: 4.435

10.  Does Alzheimer's disease begin in the brainstem?

Authors:  G Simic; G Stanic; M Mladinov; N Jovanov-Milosevic; I Kostovic; P R Hof
Journal:  Neuropathol Appl Neurobiol       Date:  2009-08-04       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.